David A. Siegel Alector, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Alector, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 394,900 shares of ALEC stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
394,900
Previous 479,700
17.68%
Holding current value
$1.44 Million
Previous $2.18 Million
15.3%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ALEC
# of Institutions
167Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$33.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$19.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$16.9 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$15.9 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$9.93 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $301M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...